Navellier & Associates Inc Mimedx Group, Inc. Transaction History

Navellier & Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$3.22 - $6.33 $60,542 - $119,016	-18,802 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$5.39 - $8.96 $23,354 - $38,823	4,333 Added 29.95%	18,802 $120,000
Q1 2018 May 21, 2018	SELL	$6.69 - $17.96 $2,515 - $6,752	-376 Reduced 2.53%	14,469 $101,000
Q4 2017 Feb 12, 2018	SELL	$10.87 - $13.9 $3,010 - $3,850	-277 Reduced 1.83%	14,845 $187,000
Q3 2017 Nov 14, 2017	BUY	$11.86 - $17.34 $179,346 - $262,215	15,122	15,122 $180,000

218

94.7M

221K

77.4K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $775M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.